Immunohematological testing and transfusion management of the prenatal patient
Advances in Clinical Chemistry · 2023
DOI: 10.1016/bs.acc.2023.08.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Clinical Chemistry, 2023. Verfasst von NurJehan Quraishy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section of Transfusion Medicine, Department of Laboratory Medicine, Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cl…. Hauptthemen laut MEDLINE: Erythroblastosis, Fetal, Anemia, Hemolytic, Autoimmune. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 163 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Transfusion Medicine, Department of Laboratory Medicine, Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, United States.
- Section of Transfusion Medicine, Department of Laboratory Medicine, Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, United States. Electronic address: sapatns@ccf.org.
Zitieren
APA
Quraishy, N., & Sapatnekar, S. (2023). Immunohematological testing and transfusion management of the prenatal patient. Advances in Clinical Chemistry. https://doi.org/10.1016/bs.acc.2023.08.002
Vancouver
Quraishy N, Sapatnekar S. Immunohematological testing and transfusion management of the prenatal patient. Advances in Clinical Chemistry. 2023. doi:10.1016/bs.acc.2023.08.002
BibTeX
@article{Quraishy2023,
author = {Quraishy, NurJehan and Sapatnekar, Suneeti},
title = {Immunohematological testing and transfusion management of the prenatal patient},
journal = {Advances in Clinical Chemistry},
year = {2023},
doi = {10.1016/bs.acc.2023.08.002}
}
EUVIMED